The Death of MONA in ACS: Part I – Morphine
…Morphine): Death: 2% vs 3%; p = 0.53 Reinfarction: 1% vs 1%; p = 0.58 Stroke: 0% vs 1%; p = 0.33 Dyspnea: 1% vs 8%; p = 0.10 Bottom…
…Morphine): Death: 2% vs 3%; p = 0.53 Reinfarction: 1% vs 1%; p = 0.58 Stroke: 0% vs 1%; p = 0.33 Dyspnea: 1% vs 8%; p = 0.10 Bottom…
…1 year Secondary: Death from any cause within 30 days after randomization, rehospitalization with myocardial infarction, rehospitalization with heart failure, and cardiovascular death and composites of these endpoints at 30…
…250 Vascular Death: 42 NNH to Cause: Major Bleed (Transfused): No Difference Minor Bleed (Not Transfused): 167 Strengths: Largest trial to date evaluating the effectiveness of Aspirin Randomized Placebo Controlled…
…in the first 48 hours was, “Highly significant benefit was achieved. 125 or 250 patients, with high or low risk, need to be treated to prevent one death.” They go…
…an opiate should not delay interventions as the cause of pain has been masked, and not treated. Have we have seen the death of MONA in ACS…Maybe. In a previous…
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.